DISPOSITION OF MEPIVACAINE AND BUPIVACAINE ENANTIOMERS IN SHEEP

Mepivacaine and bupivacaine are used clinically as racemic mixtures of enantiomers. In these studies the enantiomers of each agent were administered separately to sheep by i.v. bolus injection on separate occasions. Enantioselective disposition was deemed if the R:s ratio of the relevant pharmacokin...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of anaesthesia : BJA Vol. 67; no. 3; pp. 239 - 246
Main Author MATHER, L.E.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.09.1991
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mepivacaine and bupivacaine are used clinically as racemic mixtures of enantiomers. In these studies the enantiomers of each agent were administered separately to sheep by i.v. bolus injection on separate occasions. Enantioselective disposition was deemed if the R:s ratio of the relevant pharmacokinetic parameter differed significantly from unity. Both enantiomers of both agents were cleared principally by the liver; urinary excretion of unmetabolized agents accounted for < 2% of the doses. For R(−)- and S(+)-mepivacaine. respective mean (SEM) values of parameters were: total body clearance 1.20 (0.29) litre min−1 and 0.97 (0.20) litre min−1 (ns); total volume of distribution 144 (39) litre and 80 (21) litre (P < 0.05); slow half-life 120 (40) min and 84 (22) min (ns); mean hepatic extraction ratio 0.50 (0.14) and 0.52 (0.09) (ns); mean hepatic clearance 0.75 (0.23) litre min1 and 0.75 (0.18) litre min1 (ns). For R(+)- and s(−)-bupivacaine, respective values were: total body clearance 0.77 (0.33) litre m nd 0.53 (0.26) litre min (P<0.05); total volume of distribution 40 (10) litre and 43 (10) litre (ns); slow half-life 57 (10) min and 104 (21) min (P<0.05); mean hepatic extraction ratio 0.46 (0.15) and 0.29 (0.13) (P < 0.05); mean hepatic clearance 0.85 (0.31) litre min and 0.54 (0.26) litre min (P < 0.05). Thus there was enantioselective distribution of mepivacaine and enantioselective clearance of bupivacaine, but the magnitude of the effect was relatively small.
Bibliography:istex:11C4B9D71C17D989C3E68E02C631AEF74CD12DD2
ArticleID:67.3.239
ark:/67375/HXZ-C6059PBX-X
Present address for correspondence: Department of Anaesthesia and Pain Management, The University of Sydney, Royal North Shore Hospital, St Leonards, NSW 2065, Australia
This paper is dedicated to the memory of friend and colleague Dr Peter J. Meffin (1943-1987), who made major contributions to our knowledge of the disposition of mepivacaine and of other enantiomeric drugs before his untimely death
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-0912
1471-6771
DOI:10.1093/bja/67.3.239